鼻翼一侧抽动,国产黄色日女视频,日本中文不卡在线观看,日韩欧美精品视频第一页,免费下载午夜影院

Like2291 2019-07-25 11:23 IP：重慶

◆◆

1、P. A. Prajapati and M. M. Patel, “Formulation and in vitro evaluation of atropine sulphate viscous ocular solutions for the mydriatic and cycloplegic effect,”?International Journal of Pharmaceutical and Applied Sciences, vol. 1, no. 2, pp. 70–78, 2010.?View at Google Scholar 2、D. S. Satya, K. P. Suria, and P. P. Muthu, “Advanced approaches and evaluation of ocular drug delivery system,”?American Journal of PharmTech Research, vol. 1, no. 4, pp. 72–92, 2011.?View at Google Scholar 3、B. K. Nanjwade, D. B. Sonaje, and F. V. Manvi, “In vitro—in vivo?release of ciprofloxacin from ophthalmic formulations,”?International Journal of Pharmacy and Biotechnology, vol. 1, no. 1, pp. 23–28, 2011.?View at Google Scholar 4、Physicochemical properties and stability of nicorandil By Nagai, Hiroshi; Koizumi, Ikue; Haneda, Masatoshi; Imai, Toshikatsu; Kikuchi, Mineo; Shiba, Motoharu From Iyakuhin Kenkyu (1983), 14(6), 968-79. Language: Japanese, Database: CAPLUS 5、Sobean oil partially hydrogenated 最新德國藥典 [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥50.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥50.00

已托管

載入中...

1

Like2291 2019-07-03 15:59 IP：重慶

◆◆

需要5篇文獻(xiàn)

1.Arzneimittel Forschung/Drug research 1986 36(2)，p291-303. 2.The use of antithrombotic drugs in artery disease 3. Jonassen IB, Havelund S, Ribel U, et al. Insulin Degludec is a new generation ultra-long acting basal insulin with a unique mechanism of protraction based on multi-hexamer ormation [J]. Diabetes, 2010, 59(Suppll): All(39-OR). 4.Korsatko S, Deller S, Zahiragic S, et al. Ultra-long-acting insulin degludec: two different formulations (U100 and U200) are bioequivalent and show similar pharmacodynamics [abstract no. 2349-PO]. Diabetes. 2011;60 Suppl:A624. 5.Technology Reports of the Osaka University, , vol. 7, p. 177,182。 [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥50.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥50.00

已托管

載入中...

1

Like2291 2019-06-26 09:11 IP：重慶

◆◆

需要9篇文獻(xiàn)

1、Drugs Fut 1989, 14(9): 875 ISSN 0377-8282 Copyright Clarivate Analytics CCC: 0377-8282 DOI: 10.1358/dof.1989.014.09.103408 2、Dionne, G. (BioChem Pharma Inc.); 1,3-Oxathiolane nucleoside analogues. EP 0526253; JP 1995500317; US 5538975; WO 9303027 . 3、Hoshi, A.; Casta?er, J.; Capecitabine. Drugs Fut 1996, 21, 4, 358 4、Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1997, vol. 36, # 9, p. 816 - 818 5、DETERMINATION OF CLENBUTEROL HYDROCHLORIDE BY SEQUENTIAL INJECTION ANALYSIS COUPLED WITH CHEMILUMINESCENCE DETECTION 6、[Bioanalytic examination and pharmacokinetics of captopril. Bioequivalence studies of different captopril-containing Tensiomin preparations]. 7、Agrati A. M., De Bartolo G., Palmieri G., Minerva Med., 83, 533-536(1992) 8、Dawes J., Hodson B. A., Pepper D. S., Thromb. Haemost, 62, 945-949(1989) 9、with mercury(II) diacetate,trifluoroacetic acid . Acta Chimica Hungarica 1986 vol.122 3-4 p261-272 [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥90.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥90.00

已托管

載入中...

4

冬候鳥斯伯格 2019-06-12 11:37 IP：重慶

◆◆

國內(nèi)上市企業(yè)年報(bào)數(shù)據(jù)提取

①從任務(wù)主手中獲取指定年報(bào)數(shù)量的年報(bào)文件（PDF） ②將年報(bào)中“利潤(rùn)或合并利潤(rùn)”、“研發(fā)或研發(fā)投入”、“行業(yè)產(chǎn)品地區(qū)收入”、“治療領(lǐng)域”、“產(chǎn)銷量”、“產(chǎn)品研發(fā)投入明細(xì)”等數(shù)據(jù)填入相應(yīng)表格中（任務(wù)主提供填寫模板） ③要求仔細(xì)認(rèn)真，有責(zé)任心。 ④價(jià)格2.5元/份年報(bào)預(yù)計(jì)252份，一人84份（210元），3人共計(jì)630元。 ⑤若審核發(fā)現(xiàn)有錯(cuò)填、漏填，以每漏填，錯(cuò)填一個(gè)數(shù)據(jù)1元計(jì)量扣除賞金 ⑥以前合作做過類似項(xiàng)目的優(yōu)先考慮，如有感興趣的威客可聯(lián)系參與。 [更多]

特色服務(wù)>>數(shù)據(jù)處理

懸賞：￥630.00

㖃特色服務(wù)>>數(shù)據(jù)處理

懸賞

￥630.00

已托管

載入中...

6

water125310 2019-06-04 17:12 IP：廣州

◆◆

求USP39的CalciumGluconate和CalciumGluconateInjection信息

USP39的Calcium Gluconate和Calcium Gluconate Injection標(biāo)準(zhǔn)，要求翻譯為中文 [更多]

特色服務(wù)>>文獻(xiàn)翻譯

懸賞：￥100.00

㖃特色服務(wù)>>文獻(xiàn)翻譯

懸賞

￥100.00

已托管

載入中...

3

Like2291 2019-05-16 17:10 IP：重慶

◆◆

需要5篇文獻(xiàn)

1.論批生產(chǎn)記錄設(shè)計(jì)的有效性對(duì)產(chǎn)品質(zhì)量追溯的影響——以公司內(nèi)膠囊及片劑產(chǎn)品批生產(chǎn)記錄為例 2.Federal Health bulletin 4（1961）12:189 需要這個(gè)文獻(xiàn) 3.Morton RF, et al. Studies on the absorption, diffusion, and excretion of cycloserine. Antibiot Annu 1955-56; 3: 169-72. 4.Acta Gastroenterol Belg.1969,32（10）：771-777 A NEW ANTISPASMODIC DRUG IN THE TREATMENT OF BILIARY AND INTESTINAL DISCASCS:A CLINICAL TEST. 5.a process for preparing (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one https://priorart.ip.com/IPCOM/000238343 [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥50.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥50.00

已托管

載入中...

1

Doris_huan 2019-05-13 10:39 IP：重慶

◆◆

上藥智人才找工作，輕松賺取萬元賞金（第二期·高額懸賞）

簡(jiǎn)介：藥智人才是最專業(yè)的醫(yī)藥產(chǎn)業(yè)招聘平臺(tái)，與許多醫(yī)藥行業(yè)的知名企業(yè)都有合作，職位種類豐富，崗位更專業(yè)~ 賺取賞金規(guī)則（活動(dòng)時(shí)間：5月13日-5月17日）： 1.免費(fèi)注冊(cè)/登錄藥智人才（https://job.yaozh.com/），上傳簡(jiǎn)歷：簡(jiǎn)歷完善度≥80 可獲得50元賞金； 2.簡(jiǎn)歷完成后，并截圖藥智人才簡(jiǎn)歷板塊的完善度提交審核，并且備注藥智人才的用戶名/注冊(cè)手機(jī)信息； 3.審核通過后，賞金會(huì)在3個(gè)工作日內(nèi)審核并發(fā)放，如提交后有刪除簡(jiǎn)歷的行為，視為作弊處理，對(duì)應(yīng)賞金將會(huì)被凍結(jié)不予提現(xiàn)。 4.特別福利：簡(jiǎn)歷完善后既有機(jī)會(huì)直接內(nèi)推給名企噢~ 溫馨提示： 1.如果疑問可以聯(lián)系客服QQ：3413833812 2.一經(jīng)發(fā)現(xiàn)求職者在上傳簡(jiǎn)歷期間有作弊等行為，藥智人才將取消其賞金并凍結(jié)該筆提現(xiàn)。 3.在法律允許的范圍內(nèi)，本活動(dòng)一切解釋權(quán)歸藥智人才下期活動(dòng)預(yù)告活動(dòng)日期：5月20-5月24日賞金金額：更多賺取賞金細(xì)則5月20日揭曉噢~ [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥500.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥500.00

已托管

載入中...

7

Like2291 2019-04-28 15:40 IP：重慶

◆◆

7篇文獻(xiàn)

1.丙氨酰谷氨酰胺及其注射液的研究開發(fā) 2.A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study). Cimminiello C, Arpaia G, Polo Friz H, Boracchi P, Marano G, Spezzigu G, Visonà A. Vasa. 2015 Sep;44(5):371-9. doi: 10.1024/0301-1526/a000456. 3.2013 International Conference on Materials Engineering, ICMEN 2013 4.Orientation of substitution in the aromatic series. XVIII. Sulfonation of phenol by chlorosulfonic acid in solvents 5.Mechanism of reaction of chlorosulfonic acid with some aromatic compounds 6.Arzneimittelforschung. 1982;32(3):248-51. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing. 7.Oral treatment with the Crataegus special extract WS 1442 inhibits cardiac hypertrophy in rats with DOCA-salt or aortic banding induced hypertension [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥70.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥70.00

已托管

載入中...

2

Like2291 2019-04-28 11:59 IP：重慶

◆◆

5篇文獻(xiàn)

1.Nakashima M, Morita J, Aizawa K. Pharamacokinetics and safety of tebipenem pivoxil fine granules, an oral carbapenem antibiotic, in healthy male volunteers. Jpn J Chemother. 2009;57(S–1):90–94 2.Baba S, Yamanaka N, Suzuki K, et al. Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections. Jpn J Antibiot. 2009;62:155–177 3.Sunakawa K. Pharmacological properties and clinical performance of the novel oral carbapenem antimicrobial drug, “Tebipenem pivoxil” (Orapenem fine granules 10% for pediatric use). Jpn J Chemother. 2009;57:279–294 4.Yamanaka N, Furukawa M, Furuya, et al. Clinical efficacy of tebipenem pivoxil (ME1211), a novel oral carbapenem, in otolaryngological infections, a Phase II clinical trial (1). 45th Intersci Conf Antimicrob Agents Chemother (ICAAC) 2005; Abstract L-577 5.Iwata S, Ouchi K, Iwata N, et al. An open clinical study of tebipenem pivoxil in children with bacterial pneumonia. Jpn J Chemother. 2009;57(S–1):137–150 [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥50.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥50.00

已托管

載入中...

9

Like2291 2019-04-16 10:07 IP：重慶

◆◆

需求5篇文獻(xiàn)

1、Atropine and scopolamine premedication – Pharmacological aspects and present use in Finland 2、Identification and purity test of heparin by NMR - a summary of two years' experience at the Medical Products Agency By: McEwen I; Amini A; Olofsson I M 3、Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti 4、49-12 Metabolic Fate of Triethylenetetramine dihydrochloride (Trientine hydrochloride, TJA-250) 1. Absorption, Distribution and Excretion in Rats after Single … S Takeda, E Ono, Y Matsuzaki… - Oyo Yakuri …, 1995 - [Sendai, Japan: Oyo Yakuri … 5、49-13 Metabolic Fate of Triethylenetetramine dihydrochloride (Trientine hydrochloride, TJA-250) 2. Metabolism study in Rats Using 14C-TJA 250 S Takeda, E Ono, Y Wakui… - Oyo Yakuri …, 1995 - [Sendai, Japan: Oyo Yakuri … [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥50.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥50.00

已托管

載入中...

3

當(dāng)前位置：  首頁 > 需求大廳 > 特色服務(wù) 

㔍我要出現(xiàn)在這里 推薦任務(wù)

當(dāng)前位置：  首頁 > 需求大廳
> 特色服務(wù) 

㔍我要出現(xiàn)在這里
推薦任務(wù)